TITLE

DRUG INFORMATION SERVICES TO HIV/AIDS CARE AND SUPPORT CENTRE IN RESOURCE LIMITED SETTINGS

AUTHOR(S)
VIGNESHWARAN, E.; REDDY, Y. PADMANABHA; DEVANNA, N.
PUB. DATE
October 2013
SOURCE
Asian Journal of Pharmaceutical & Clinical Research;Oct2013 Supplement, p175
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Drug information services are considered as a major resource to provide patient counseling in clinical basis and to provide pharmaceutical care to improve rational use of medicines. In India, the drug information services are usually provided by the pharmacists those who are servicing in academic institutions and hospitals. Quality assurance is an important process required for continuous development and improvement. Hence, the present study was conducted to evaluate drug information services provided by clinical pharmacist of pharmacy practice department to HIV/AIDS care and support center in a resource limited settings. Drug information Queries received by the center was answered by clinical pharmacist of pharmacy practice department after analyzing by using modified systematic approach for their completeness, straight forwardness, reliability of answers and the reliability of references used to answer the queries from both the providers and receivers perspective. Over all it was observed that our drug information services are useful for health care professional in their clinical practice. As a part of pharmaceutical care the drug information service, provided by our pharmacy practice department could serve the need of health care professionals for better patient care were acceptable.
ACCESSION #
92033526

 

Related Articles

  • Use and cost of antiretrovirals in France 1995-2000: an analysis based on the Medical Dossier on Human Immunodeficiency (release 2) database. Flori, Yves A.; le Vaillant, Marc // PharmacoEconomics;2004, Vol. 22 Issue 16, p1061 

    Objective: To assess the temporal relationship between the uptake of more aggressive antiretroviral (ARV) therapy and the use and cost of hospital treatment for HIV-infected patients in France from 1995 to 2000 from a hospital perspective.Methods: Analysis of evolutions...

  • Pharmacy and HIV testing: A good start...finally. Stergachis, Andy // Journal of the American Pharmacists Association: JAPhA;Sep/Oct2014, Vol. 54 Issue 5, p476 

    An introduction to the journal is presented in which the editor discusses the role of pharmacy in addressing the HIV/AIDS epidemic.

  • Development of a unified web-based national HIV/AIDS information system in China. Mao, Yurong; Wu, Zunyou; Poundstone, Katharine; Wang, Changhe; Qin, Qianqian; Ma, Ye; Ma, Wei // International Journal of Epidemiology;Dec2010 Supplement 2, Vol. 39 Issue suppl_2, pii79 

    Background In the past, many data collection systems were in operation for different HIV/AIDS projects in China. We describe the creation of a unified, web-based national HIV/AIDS information system designed to streamline data collection and facilitate data use.Methods Integration of separate...

  • Costing of scaling up HIV/AIDS treatment in Mexico. Bautista-Arredondo, Sergio; Dmytraczenko, Tania; Kombe, Gilbert; Bertozzi, Stefano M. // Salud Pública de México;nov2008 Supplement, Vol. 50, pS437 

    Objective. To determine the net effect of introducing highly active antiretroviral treatment (HAART) in Mexico on total annual per-patient costs for HIV/AIDS care, taking into account potential savings from treatment of opportunistic infections and hospitalizations. Material and Methods. A...

  • Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre. Beck, E.J.; Mandalia, S.; Griffith, R.; Beecham, J.; Walters, M.D.S.; Boulton, M.; Miller, D.L.; Walters, M D // PharmacoEconomics;2000, Vol. 17 Issue 1, p53 

    Objective: To describe the use of hospital and community services for children infected with HIV and estimate the cost per patient-year by stage of HIV infection during the era of antiretroviral monotherapy.Design: Data on the use of hospital services were collected...

  • CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation? Althoff, Keri N.; Gebo, Kelly A.; Gange, Stephen J.; Klein, Marina B.; Brooks, John T.; Hogg, Robert S.; Bosch, Ronald J.; Horberg, Michael A.; Saag, Michael S.; Kitahata, Mari M.; Eron, Joseph J.; Napravnik, Sonia; Rourke, Sean B.; Gill, M. John; Rodriguez, Benigno; Sterling, Timothy R.; Deeks, Steven G.; Martin, Jeffrey N.; Jacobson, Lisa P.; Kirk, Gregory D. // AIDS Research & Therapy;2010, Vol. 7, p45 

    We assessed CD4 count at initial presentation for HIV care among ≥50-year-olds from 1997-2007 in 13 US and Canadian clinical cohorts and compared to <50-year-olds. 44,491 HIV-infected individuals in the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) were...

  • Health Workers Debunk CDC Study on Link Between HIV, Surgery. Harding, Rick // Advocate;3/26/91, Issue 573, p12 

    Reports that medical experts condemned a widely-publicized estimate by the Centers for Disease Control (CDC) that between 13 to 128 patients across the U.S. may have contracted HIV, the suspected AIDS virus, through dental work or surgery. Allegations by health professionals that the CDC study...

  • The AIDS crisis: review of psychological issues and implications, with special reference to the South African situation. Lindegger, Graham; Wood, Greg // South African Journal of Psychology;Mar95, Vol. 25 Issue 1, p1 

    AIDS represents a major challenge to the health care industry. The behavioural sciences, especially psychology, have important contributions to make to various aspects of AIDS and its prevention. This article reviews the stages in the development of AIDS, examining the psychological issues and...

  • Spending on HIV: no pattern between epidemic types.  // PharmacoEconomics & Outcomes News;1/9/2010, Issue 594, p9 

    The article discusses a study of the spending on HIV treatment in low-income and middle-income countries. Results showed that a total of 2.6 billion U.S. dollars was spent on HIV programmes by the countries involved in the study. The highest spending per capital was posted by Botswana, which...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics